Watchmaker Genomics Licenses CRISPR Technology to Improve DNA Sequencing Efficiency
The company plans to use CRISPR-Cas9 as a binding tool to address bottlenecks in next-generation sequencing workflows.
Read MorePosted by CLP Edit Staff | Feb 17, 2026 | Library Preparation Systems Flow |
The company plans to use CRISPR-Cas9 as a binding tool to address bottlenecks in next-generation sequencing workflows.
Read MorePosted by CLP Edit Staff | Feb 11, 2026 | Infectious Diseases |
The 3-test panel detects antibodies for parasitic infections that affect up to 45 million people globally and are linked to bile duct cancer.
Read MorePosted by CLP Edit Staff | Feb 10, 2026 | Sexually Transmitted Diseases |
The HIV self-test has received Health Canada approval, making it the first oral HIV self-test available in Canada. Results are provided in 20 minutes with an oral swab.
Read MorePosted by CLP Edit Staff | Feb 9, 2026 | Flu & Respiratory Infections |
Visby Medical and Watchmaker Genomics have partnered to develop at-home PCR respiratory tests designed to overcome molecular inhibitors found in unprocessed clinical samples, according to a joint announcement.
Read MorePosted by CLP Edit Staff | Feb 3, 2026 | Infectious Diseases |
Vanderbilt Medical Laboratories has implemented in-house rapid antigen testing for histoplasmosis, reducing turnaround times and improving patient management, according to clinical staff and recent case reports.
Read More